Apoptosis of motor neurons is a well-documented feature in amyotrophic lateral sclerosis (ALS) and related motor neuron diseases (MNDs). However, the role of apoptosis in the pathogenesis of these diseases remains unresolved. One possibility is that the affected motor neurons only succumb to apoptosis once they have exhausted functional capacity. If true, blocking apoptosis should confer no therapeutic benefit. To directly investigate this idea, we tested whether tissue-specific deletion in the mouse CNS of BCL2-associated X protein (BAX) and BCL2-homologous antagonist/killer (BAK), 2 proapoptotic BCL-2 family proteins that together represent an essential gateway to the mitochondrial apoptotic pathway, would protect against motor neuron degeneration. We found that neuronal deletion of Bax and Bak in a mouse model of familial ALS not only halted neuronal loss, but prevented axonal degeneration, symptom onset, weight loss, and paralysis and extended survival. These results show that motor neurons damaged in ALS activate the mitochondrial apoptotic pathway early in the disease process and that apoptotic signaling directly contributes to neuromuscular degeneration and neuronal dysfunction. Hence, inhibiting apoptosis upstream of mitochondrial permeabilization represents a possible therapeutic strategy for preserving functional motor neurons in ALS and other MNDs.
Nichole A. Reyes, Jill K. Fisher, Kathryn Austgen, Scott VandenBerg, Eric J. Huang, Scott A. Oakes
Title and authors | Publication | Year |
---|---|---|
ALS Mutation FUS-R521C Causes DNA Damage and RNA Splicing Defects
Haiyan Qiu, Sebum Lee, Yulei Shang, Wen-Yuan Wang, Kin Fai Au, Sherry Kamiya, Sami Barmada, steven finkbeiner, Hansen Lui, Caitlin Carlton, Amy Tang, Michael Oldham, Hejia Wang, James Shorter, Anthony Filiano, Erik Roberson, Warren Tourtellotte, Bin Chen, Li-Huei Tsai, Eric Huang |
Journal of Clinical Investigation | 2014 |
Mitochondrial dysfunction in amyotrophic lateral sclerosis - a valid pharmacological target?: Mitochondrial dysfunction in ALS
H Muyderman, T Chen |
British Journal of Pharmacology | 2014 |
Role of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosis
W Tan, P Pasinelli, D Trotti |
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease | 2014 |
Species-dependent neuropathology in transgenic SOD1 pigs
H Yang, G Wang, H Sun, R Shu, T Liu, CE Wang, Z Liu, Y Zhao, B Zhao, Z Ouyang, D Yang, J Huang, Y Zhou, S Li, X Jiang, Z Xiao, XJ Li, L Lai |
Cell Research | 2014 |
Glycoursodeoxycholic Acid Reduces Matrix Metalloproteinase-9 and Caspase-9 Activation in a Cellular Model of Superoxide Dismutase-1 Neurodegeneration
AR Vaz, C Cunha, C Gomes, N Schmucki, M Barbosa, D Brites |
Molecular Neurobiology | 2014 |
Microglia centered pathogenesis in ALS: insights in cell interconnectivity
D Brites, AR Vaz |
Frontiers in cellular neuroscience | 2014 |
ATF3 expression improves motor function in the ALS mouse model by promoting motor neuron survival and retaining muscle innervation
R Seijffers, J Zhang, JC Matthews, A Chen, E Tamrazian, O Babaniyi, M Selig, M Hynynen, CJ Woolf, RH Brown |
Proceedings of the National Academy of Sciences | 2014 |
Golgi fragmentation precedes neuromuscular denervation and is associated with endosome abnormalities in SOD1-ALS mouse motor neurons
V Dis, M Kuijpers, ED Haasdijk, E Teuling, SA Oakes, CC Hoogenraad, D Jaarsma |
Acta Neuropathologica Communications | 2014 |
Is the risk of motor neuron disease increased or decreased after cancer? An Australian case-control study
A Stoyanov, R Pamphlett |
PloS one | 2014 |
Stem Cell Factor-Activated Bone Marrow Ameliorates Amyotrophic Lateral Sclerosis by Promoting Protective Microglial Migration
Terashima T, Kojima H, Urabe H, Yamakawa I, Ogawa N, Kawai H, Chan L, Maegawa H |
Journal of Neuroscience Research | 2014 |